# Panel Brief — Round 2 independent review of manuscript v1.1.0

## Independence discipline (MANDATORY)

You are reviewing a manuscript that has already been through one revision round.
**This must not influence you.** Treat the manuscript as a fresh first submission.

**Forbidden to read (do not open, do not trust summaries of):**
- `05_reports/REVIEW_round1_20260926.md` and any `REVIEW_*.md`
- the entire `05_reports/review/` directory (Round-1 expert files A1–A5)
- `05_reports/RESPONSE_*.md`, `REVISION_*.md`, `CHANGELOG*.md`
- `SUBMISSION_MANIFEST.md`, `GITHUB_DEPOSIT_SOP.md`, `author_verification_statement.md`
- any other reviewer's output file inside `05_reports/review_r2/` (this round's dir)
- the project `README.md`, `PIPELINE.md`, task-status / overview files

Do **not** assume the manuscript is mature or has "already passed" anything.
Every judgement must come from text or source data you read yourself.
**Any claim in the manuscript that you CAN verify against source data, you MUST verify.**
A review that only paraphrases the manuscript text is incomplete.

## What the manuscript is (for context only)

Title: *Immunoparalysis hub genes of the MARS immunosuppressed endotype in sepsis:
a multi-omics dissection and in-silico drug repositioning* (single-author, v1.1.0).

Claimed study: reanalysis of a published sepsis transcriptomic cohort (GSE65682-style
MARS endotypes) to (a) define a Mars1 immunosuppressed endotype with coherent
down-regulation of antigen-presentation / monocytic genes; (b) identify a 6-gene hub
(CD74, HLA-DQA1, CD14, FCGR3A, HAVCR2, FIS1) and a 30-gene immune-risk signature
(CV AUC 0.659, training 0.750, external E-MTAB-4451 AUC 0.638); (c) reposition
immunostimulatory agents via a LINCS L1000 reverse-connectivity screen (azithromycin,
lenalidomide) plus a mechanism-anchored annotation of IL-7 / GM-CSF / IFN-γ / thymosin
α1 / BCG; (d) a two-sample MR (eQTLGen × UK Biobank sepsis 28-day-death GWAS,
ieu-b-5086) of the hub genes as a hypothesis-generating layer.

Target venue intent (author's): a methods-honest translational / computational
biology journal; the prior round flagged possible desk-reject risks if over-claims
persist. Your job is to judge the CURRENT text honestly.

## Output contract (every item needs all four parts)

- 【Problem】 one sentence, no hedging.
- 【Evidence】 pinned to `manuscript.md:line` or `section` + exact numbers; numbers
  you cite MUST be ones you recomputed or re-extracted yourself from the source CSVs.
- 【Why it matters】 concrete effect on conclusions / credibility / acceptance.
- 【Specific fix】 a paste-ready English replacement sentence, OR an explicit spec for
  a new analysis (variables, strata, output columns).
  "Consider strengthening the discussion" is BANNED.

## Also required sections

- § Stands up (≥3, with evidence) — things you suspected but found correct. Deliverable.
- § Questions for the authors — what you need to know; do not guess answers.
- § What I actually checked — files read, commands run, values recomputed vs the
  manuscript's, with the discrepancy (or "none") stated explicitly.

## Mandatory numeric checks (incomplete review if skipped)

Source data live in `03_results/`. Re-extract and compare to the manuscript:

1. **Table 1 / §3.1 directionality** — `S01_immunoparalysis_direction.csv`.
   Recompute: how many of 25 genes are Mars1_down vs Mars1_up; how many have
   adj.P.Val < 0.05; how many are both down AND adj.P<0.05. Spot-check the 8 genes
   the manuscript names (HLA-DRB1, CD74, CD14, FCGR3A, HAVCR2, HLA-DRA, LYZ, ITGAM):
   logFC and adj.P must match the CSV exactly. Confirm ITGAM is correctly flagged
   NOT significant at FDR<0.05 in the text.
2. **Prognosis AUC / §3.4, §3.5** — `S06_auc_compare.csv`. Cross-check: signature CV
   0.659, train 0.750, IRG benchmark 0.619 (E-MTAB-4451) and 0.648 (GSE65682).
   The manuscript also cites an **external** AUC 0.638 (95% CI 0.532–0.748) on
   E-MTAB-4451; trace this to its producing script/figure and confirm it is a
   fixed-orientation out-of-sample score, not the same cohort as the CV.
3. **Drug metric / §2.8, §3.7, Table 2** — `08_candidates_drugs.csv` (columns
   n_target_genes, n_rescue_mars1down, rescue_fraction) and
   `08b_clinical_translation.csv`. Confirm the manuscript's `response_gene_concordance`
   is defined as curated-response-gene overlap (NOT a direct protein-target overlap),
   and that the per-drug fractions (IL-7 5/5=1.0, GM-CSF 5/6=0.833, IFN-γ 5/7=0.714,
   azithromycin 2/3=0.667, lenalidomide 2/5=0.40, thymosin 2/5=0.40, BCG 1/5=0.20)
   are reported consistently and not confused with a target-based score. Confirm the
   "IFN-γ rescued 5/5 antigen-presentation genes" claim resolves to the 5 AP genes
   in its rescue_genes list.
4. **LINCS L1000 / §3.9** — `S08_l1000_candidate_scores.csv`. Confirm azithromycin
   wtcs = 0.0626 and lenalidomide wtcs = 0.2058 (NOT 1.17). Confirm the query is
   described as 22 L1000-measurable consensus genes (20 Mars1-down + 2 Mars1-up
   exhaustion markers PDCD1, LAG3); confirm HAVCR2 / FCGR3A are stated as absent
   from the L1000 platform and excluded by design. Verify "BRD-" prefixes are
   described as Broad anonymized IDs, not a BET-inhibitor pharmacologic class.
5. **MR / §2.10, §3.10, Table 3–4** — `10_genetics_mr_outcome5086_harmonised.csv`,
   `10_genetics_mr_outcome4982_harmonised.csv`, and `10_genetics_mr_harmonised.csv`.
   Confirm the eQTLGen×UKB sample-overlap limitation is disclosed and that no
   overlapping-participant correction was applied. Confirm CD14 MR-Egger OR≈0.906
   is reported as suggestive only (few instruments, not corroborated by IVW /
   weighted median). Confirm STROBE-MR harmonisation tally is traceable to the
   *_harmonised.csv files.

## Environment traps (so you don't burn budget)

- CSV floats are full-precision (e.g. `1.0657215850547649e-15`); the manuscript
  rounds them (e.g. `1.1×10⁻¹⁵`). Rounding is fine; order-of-magnitude / sign /
  significance errors are not.
- Windows path separators: use forward slashes in any shell command.
- Do NOT try to run the full pipeline; just read the already-computed CSVs above.
- Numbers in `manuscript.md` use Unicode (Δ, ×, ⁻¹⁵, –). Grep with that in mind.

## Tool-talk forbidden

Do not describe which tools you used. Write review comments only.
Save your full report with the Write tool to the path given in your dispatch prompt;
returning only a chat summary is task failure.
